Skip to main content

Table 1 Resource and costing: data sources (updated to 2011 prices)

From: Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Data Cost (€) Source
Annualised cost of outpatient care (based on Spanish data from 2002) 2058.60 Bobes et al., 2004 [30]
Inpatient cost of relapse management based on 2000 Spanish data 4226.91 Peiró et al., [31]
Outpatient cost of relapse management based on 2000 Spanish data (42.94% of inpatient cost) 884.38 Peiró et al., [31]
Cost of switching treatment (assumed at three times the routine cost of schizophrenia management = 3 × €5.64) 16.92/day Bobes et al., 2004 [30]
NICE (2009) [32]
Cost associated with post-injection syndrome management, assuming 3 days of additional inpatient hospitalisation (€157.00), one additional day in an emergency psychiatric ward (€107.90) and one additional visit to a psychiatrist (€62.10) = €327.00 based on 2005 costs 368.53 Bernardo et al., 2006 [33]
Cost of administration: OLAI, based on a nurse visit cost of €24.56 plus 3 hours observation time for a group of 8 patients at €10.21 34.77 http://www.oblikue.com/bddcostes/
Cost of administration: RLAI based on a nurse visit cost of €24.56 24.56 http://www.oblikue.com/bddcostes/